• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Kalbe Farma Tbk PT

+ Add to Watchlist

LCLA:GR

0.108 EUR 0.003 2.70%

As of 05:54:34 ET on 07/14/2014.

Snapshot for Kalbe Farma Tbk PT (LCLA)

Open: 0.107 Day's Range: 0.097 - 0.113 Volume: 0
Previous Close: 0.111 52wk Range: 0.063 - 0.119 1-Yr Rtn: +13.80%

Stock Chart for LCLA

No chart data available.
  • LCLA:GR 0.108
  • 1D
  • 1M
  • 1Y
0.111
Interactive LCLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LCLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 35.4330
Relative P/E vs. DAX -
Earnings Per Share (IDR) (ttm) -
Est. EPS (IDR) (12/2014) 48.3850
Est. PEG Ratio 2.1523
Market Cap (M EUR) 5,062.51
Shares Outstanding (M) 46,875.12
30 Day Average Volume 1,882
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.98%
Cash Dividend (IDR) 17.0000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 49.65%
Next Earnings Announcement 07/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LCLA

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for LCLA

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for LCLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil